Regulation

Can AI Make Prior Authorization Happen Instantly?
Process Can AI Make Prior Authorization Happen Instantly?

The seemingly endless cycle of faxes, phone calls, and administrative paperwork that defines prior authorization has long been a source of frustration for healthcare providers, but a new wave of artificial intelligence is poised to dismantle this archaic process from within the clinical encounter

Claude for Healthcare and Life Sciences – Review
Care Claude for Healthcare and Life Sciences – Review

The monumental weight of administrative bureaucracy and the painstaking slowness of scientific discovery have long defined the operational realities of healthcare and life sciences, creating persistent friction that impacts everything from patient care to drug development. Anthropic’s expansion of i

Key Strategies Boost Outpatient Program Retention
Care Key Strategies Boost Outpatient Program Retention

The expanding landscape of behavioral healthcare hinges on the successful implementation of intermediate care models, yet their very foundation is threatened by a persistent and costly retention crisis. Intensive Outpatient (IOP) and Partial Hospitalization (PHP) programs represent a critical

Trump-Linked Think Tank Launches Healthcare AI Initiative
Technology Trump-Linked Think Tank Launches Healthcare AI Initiative

Faisal Zain is a leading expert in medical technology, known for his work at the intersection of healthcare innovation and public policy. As a key figure in a new AI initiative at the Paragon Health Institute, a think tank with close ties to the Trump administration, he is shaping the conversation

Can New Funding Fix Clinical Trial Patient Recruitment?
Organizational Governance Can New Funding Fix Clinical Trial Patient Recruitment?

The journey of a life-saving drug from a laboratory concept to a patient’s hands is one of the most complex and expensive undertakings in modern science, yet it is often stalled not by scientific complexity, but by the profoundly human challenge of finding the right people to participate in c

Is Innovation Enough for Biopharma's Survival?
Care Is Innovation Enough for Biopharma's Survival?

The echo of groundbreaking scientific achievement in the biopharmaceutical sector is being increasingly muffled by the persistent drumbeat of an unsustainable business model, creating a dissonance that threatens the industry's long-term health. An exhaustive analysis of strategic forecasts and

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later